14 March 2022 17:30
Patients with thalassemia received bone marrow transplants
Bone marrow transplantations were performed on 32 patients with thalassemia in accordance with “State Program on Fighting of Thalassemia for 2015-2020” implemented by the State Agency on Mandatory Health Insurance (Agency) since April 2020.
Bone marrow donors were brothers and sisters of patients. Surgeries were performed at the Thalassemia division (Thalassemia Center) of the National Center for Hematology and Transfusion subordinated to the Administration of the Regional Medical Divisions (TABIB).
The head of the Bone Marrow Transplantation Section at the Thalassemia division of National Center for Hematology and Transfusion, hematologist Nargiz Aliyeva says that in genetic and malignant hematological diseases, several problems arise in the process of creation of blood cells in the bone marrow, as the bone marrow, which produces stem cells, loses its normal functions: “Bone marrow transplantation plays an important role in the treatment of these diseases. Bone marrow transplant involves transferring the stem cells to a patient to produce healthy blood cells. With this method of treatment, patients get a chance to be completely cured of inherited and malignant hematological diseases. In many cases after surgery, the recipient's organs and tissues recognize the donor's lymphocytes as foreign, and the recipient's lymphocytes try to repel them. In this case, to avoid side effects, the patient is prescribed protective medications before and after the transplantation.”
Nargiz Aliyeva added that the transferred stem cells start to produce new bone marrow in about 3 weeks. During this period, the patient receives blood products (erythrocytes, platelet masses, fresh frozen plasma) and antibacterial, antiviral, antifungal treatments.
We would like to emphasize that patients are provided free of charge both with medications used in preparation for surgery (for chemotherapy), and immunosuppressants prescribed for the reception of stem cells by the patient's immune system.
It should be noted that bone marrow transplantation, prevention of complications of the disease, preoperative laboratory tests are carried out free of charge in accordance with the “State Program on Fighting of Thalassemia for 2015-2020”.
Thalassemia is an inherited blood disorder. The disease is associated with impaired synthesis of hemoglobin in red blood cells. People with thalassemia have almost no specific complaints. They are also found to be carriers of thalassemia by chance, as a result of a blood test performed for examination of another problem.
If only one of the parents is a carrier of thalassemia, the probability of the child having thalassemia is zero. However, when both father and mother are carriers of thalassemia, their child is 25% more likely to be completely healthy, 50% more likely to be a carrier of thalassemia, and 25% more likely to be born with thalassemia.
News
İcbari tibbi sığorta ilə 182 000-dən artıq doğuş aparılıb
16 July 2024 11:10
Diz oynağının endoprotezləşməsində İsveçrə istehsalı protezlərdən istifadə olunur
12 July 2024 10:42
Kəskin orta otitin cərrahi müalicəsi icbari tibbi sığorta ilə qarşılanır
09 July 2024 11:11
Tiroidektomiya əməliyyatı icbari tibbi sığorta ilə ödənişsizdir
05 July 2024 10:25
İcbari tibbi sığorta ilə qasıq yırtığı açıq və laparoskopik üsulla icra olunur
01 July 2024 15:18
İcbari Tibbi Sığorta üzrə Dövlət Agentliyinin nümayəndə heyəti Yaponiyaya işgüzar səfər edib
28 June 2024 10:51
İcbari tibbi sığorta ilə 540 splenektomiya əməliyyatı icra olunub
24 June 2024 14:52
Zaur Əliyev Goranboy şəhərində vətəndaşları qəbul edib
21 June 2024 17:00
İcbari tibbi sığorta uşaqlığın çıxarılması əməliyyatını qarşılayır
21 June 2024 10:57
Agentlik, TƏBİB və Ankara Universiteti üçtərəfli anlaşma memorandumu imzaladı
14 June 2024 14:49